Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025)
Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.69% |
| Sep 30, 2025 | 69.12% |
| Jun 30, 2025 | -22.84% |
| Mar 31, 2025 | -69.95% |
| Dec 31, 2024 | 52.74% |
| Sep 30, 2024 | -586.18% |
| Jun 30, 2024 | 69.67% |
| Mar 31, 2024 | 34.67% |
| Dec 31, 2023 | -46.75% |
| Sep 30, 2023 | 69.84% |
| Jun 30, 2023 | -67.49% |
| Mar 31, 2023 | 20.60% |
| Dec 31, 2022 | -62.73% |
| Sep 30, 2022 | 57.92% |
| Jun 30, 2022 | -496.35% |
| Mar 31, 2022 | 66.64% |
| Dec 31, 2021 | 27.13% |
| Sep 30, 2021 | -100.16% |
| Jun 30, 2021 | 80,583,485.08% |
| Mar 31, 2021 | 99.86% |